funding-eu EU Horizon Europe HORIZON-MISS-2027-02 HORIZON-MISS-2027-02-CANCER-03 Anticancer therapy Biophotonics, Imaging, image and data processing Cancer and its biological basis Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes EU — Italia · scadenza 21/09/2027
